Cell Therapy Manufacturing Key Players-Business, Deal & Patent Strategies
The global cell therapy manufacturing market is estimated to grow from USD 3.92 billion in 2022 at 16% CAGR (2023-2032) to reach an estimated USD 16.40 billion by 2032.
Cell Therapy Manufacturing Top Companies
- Merck KGaA
- Thermo Fisher Scientific
- Catalent, Inc
- Bio-Techne
- Cytiva
- Lonza
- The Discovery Labs
- Novartis AG
- Bristol-Myers Squibb Company
- Gilead Sciences, Inc.
US Import Data for Cell Culture Media, Biological Reagents, Cryopreservation Equipment, and Medical Equipment for Cell Processing
| Consignee Name | Shipper Name | Loading Port | Unloading Port | Sum of Quantity | Sum of Weight (kg) |
| Fisher and Paykel Healthcare USA KY | Fisher and Paykel Healthcare Limited | 61443, Tauranga | 1601, Charleston, SC | 2,805,193 | 1,359,735 |
| Cerus Corp | Cerus Europe B V | 42157, Rotterdam | 1401, Norfolk, VA | 990,576 | 363,172 |
| Eucatex of North America Inc | Eucatex Industria e Comercio Ltd. | 35177, Sao Paulo | 1303, Baltimore, MD | 901,730 | 5,319,866,664 |
| Eucatex of North America Inc | Eucatex Industria e Comercio Ltd. | 35177, Sao Paulo | 1805, Fernandina Beach, FL | 796,910 | 2,646,641,799 |
| Fisher and Paykel Healthcare USA KY | Fisher and Paykel Healthcare Limited | 61443, Tauranga | 1401, Norfolk, VA | 1,632,720 | 492,769 |
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking
